BioSpace News Archive

Net earnings of SEK -84.9 m (111.7), net earnings of SEK -22.4 m excluding DTx launch. Net earnings also impacted by a material one-time tax adjustment of SEK -43.5 m.

Clinical Laserthermia Systems AB, announced the American Medical Association has approved its application and issued a Category level III Current Procedural Terminology reimbursement code for “transperineal focal laser ablation of malignant prostate tissue with ultrasoundguidance.” The new code is expected to be formally finalized and active from July 1, 2021.

Follows completion of a first-in-human dose-rising study of a single focal injection of NanoPac in patients with local prostate cancer

Haemonetics Corporation announced that financial results for its second quarter fiscal 2021, which ended September 26, 2020, are available on its Investor Relations website.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced today financial results for the three- and nine-month periods ended September 30, 2020.

Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the third quarter ended September 30, 2020, prior to the open of the U.S. financial markets on Wednesday, November 11, 2020.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it will hold its quarterly earnings conference call for the period ending September 30, 2020 with investors and analysts at 5 p.m. EST on Monday, November 9, 2020.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the third quarter of 2020 and provided a corporate update.

Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that members of the management team will participate in three upcoming virtual investor conferences during the month of November.

According to the report, the global mHealth monitoring diagnostic medical devices market was valued at US$ 29.05 Bn in 2018 and is projected to expand at a CAGR of 20.5% from 2019 to 2027